ACHIEVE LIFE SCIENCES, INC. 8-K

What Happened

• Achieve Life Sciences, Inc. (ACHV) announced on March 24, 2026 that it has reported its financial results for the fourth quarter and the year ended December 31, 2025. The company issued a press release with those results, and the release is furnished as Exhibit 99.1 to the Form 8-K (Item 2.02).

Key Details

• Filing date: March 24, 2026 (Form 8-K, Item 2.02).
• Period covered: Fourth quarter and full year ended December 31, 2025.
• Press release: Furnished as Exhibit 99.1 to the 8-K; the filing also references the Inline XBRL cover page interactive data file (Exhibit 104).
• The 8-K discloses the issuance of the results but does not itself include additional financial tables beyond the furnished press release.

Why It Matters

• This filing provides investors the company’s latest reported quarterly and annual financial results (earnings and financial condition), which are key inputs for assessing performance, revenue trends, profitability, and cash runway.
• Retail investors should read the attached press release (Exhibit 99.1) and the company’s periodic reports for full numerical details, context, and any management commentary or guidance disclosed with the results.